Trial of everolimus-eluting stents or bypass surgery for coronary disease.

  title={Trial of everolimus-eluting stents or bypass surgery for coronary disease.},
  author={Seung-jung Park and Jung Min Ahn and Young-Hak Kim and D G Park and Sung Cheol Yun and Jong-Young Lee and Soo-Jin Kang and Seung Whan Lee and Cheol Whan Lee and Seong-wook Park and Suk Jung Choo and Cheol Hyun Chung and Jae Won Lee and David Jacques Cohen and Alan Yeung and Seung Ho Hur and Ki Bae Seung and Tae Hoon Ahn and Hyuck-moon Kwon and D Q Lim and Seung Woon Rha and Myung Ho Jeong and Bong-Ki Lee and Damras Tresukosol and Guo Sheng Fu and Tiong Kiam Ong},
  journal={The New England journal of medicine},
  volume={372 13},
BACKGROUND Most trials comparing percutaneous coronary intervention (PCI) with coronary-artery bypass grafting (CABG) have not made use of second-generation drug-eluting stents. METHODS We conducted a randomized noninferiority trial at 27 centers in East Asia. We planned to randomly assign 1776 patients with multivessel coronary artery disease to PCI with everolimus-eluting stents or to CABG. The primary end point was a composite of death, myocardial infarction, or target-vessel… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 92 extracted citations

Reviewing hybrid coronary revascularization: challenges, controversies and opportunities.

Expert review of cardiovascular therapy • 2016
View 4 Excerpts
Highly Influenced

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery • 2018
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…